Physician profile
David B Tick
NPI 1972571313
$3,685.20
in general payments reported to CMS, 2019-2025
41 companies · $235 in 2025
The $235 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $401 · 2020: $351 · 2021: $1,189 · 2022: $919 · 2023: $376 · 2024: $215 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $826.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $825.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $730.98 | 2019-2023 | Xarelto |
| Abbvie INC. | $563.54 | 2021-2025 | Qulipta, Vraylar |
| Astrazeneca Pharmaceuticals LP | $305.92 | 2019-2023 | Farxiga |
| Lilly USA, LLC | $269.37 | 2019-2023 | Mounjaro, Trulicity |
| Novartis Pharmaceuticals Corporation | $175.34 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $114.59 | 2019-2023 | Jardiance |
| Gilead Sciences, INC. | $111.93 | 2020-2022 | |
| Novo Nordisk INC | $104.35 | 2020-2022 | |
| Amarin Pharma, INC. | $103.99 | 2019-2021 | |
| Ironwood Pharmaceuticals, INC | $102.73 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $100.63 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $93.60 | 2024-2025 | Ponvory, Fanapt |
| Phathom Pharmaceuticals, INC. | $73.68 | 2025 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $65.49 | 2021-2024 | |
| Amgen INC. | $65.39 | 2019-2023 | Repatha |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Tick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.